An Empirical Analysis of Vulnerability to Poverty in Nigeria: Do Household and Regional Characteristics Matter?

by Peter N. Mba, Emmanuel O. Nwosu, Anthony Orji
Published 2018-07-01

Tool selection and kitting : technical and organizational issues

by Stein, Jeffrey N., M.B.A. (Jeffrey Nicholas). Massachusetts Institute of Technology
Published 2013

Are Wealthy Countries Always Healthy? Health Outcomes and Public Health Spending Nexus in Nigeria

by Anthony Orji, Jonathan E. Ogbuabor, Peter N. Mba, Onyinye I. Anthony-Orji
Published 2021-08-01

Traditional lipid profile and underdiagnosis of chronic complications in diabetic population in Nigeria

by Blessing K. Myke-Mbata, Samuel C. Meludu, Chudi. E. Dioka, Izuchukwu N. Mba
Published 2019-10-01

Identification of co-circulating pathogens that are clinically indistinguishable from Lassa fever during the 2018 Lassa outbreak in Nigeria

by J. Ashcroft, E. Ndodo, C. Dannwafor, B. Gannon, H. Bagnall, N. Mba, E. Ilori, A. Olayinka, C. Ihekweazu
Published 2020-12-01

Emergence of Neisseria meningitidis serogroup X in the 2017/2018 Cerebrospinal Meningitis outbreak, Nigeria

by R. Amaza, M. Popoola, E. Ekeng, M. Antonio, C.B. Okoi, C. Ameh, M.S. Balogun, P. Nguku, O. Aderinola, A. Adebayo, N. Mba, C. Ihekweazu
Published 2020-12-01

A description of Lassa Fever mortality during the 2019 outbreak in Nigeria

by S. Mba, W. Ukponu, U. Adekanye, M. Saleh, E. Agogo, C. Dan-Nwafor, L. Amao, O. Oparah, L. Olajide, A. Oyegoke, N. Mba, E. Ilori, C. Ihekweazu
Published 2020-12-01

Reemergence of Yellow Fever in Nigeria 2018: The Anambra state experience

by O. Okoro, S. Owoicho, U. Nwangwu, E. Eloy, I. Yohanna, C. Okedo, N. Uba, C. Dan-Nwafor, M.S. Balogun, M. Balogun, W. Nwachukwu, N. Mba, P. Nguku, C. Ihekweazu
Published 2020-12-01

Effectiveness of Isometric Exercise and Counseling on Level of Pain Among Patients With Knee Osteoarthritis

by Ponnu Kangeswari RN, RM, BSN, MSC(N), MBA(HM), PhD, Kamala Murali RN, RM, BSN, MSc(N), PhD, Judie Arulappan RN, RM, MSc (N), PhD, DNSC
Published 2021-04-01

One and done: Reasons principal investigators conduct only one FDA-regulated drug trial

by Amy Corneli, PhD, MPH, Christine Pierre, RN, Terri Hinkley, RN, BScN, MBA, CCRC, Li Lin, MS, Christopher B. Fordyce, MD, MSc, Gerrit Hamre, MA, Matthew T. Roe, MD, MHS
Published 2017-06-01

Human mobility patterns and malaria importation on Bioko Island

by Carlos A. Guerra, Su Yun Kang, Daniel T. Citron, Dianna E. B. Hergott, Megan Perry, Jordan Smith, Wonder P. Phiri, José O. Osá Nfumu, Jeremías N. Mba Eyono, Katherine E. Battle, Harry S. Gibson, Guillermo A. García, David L. Smith
Published 2019-05-01

Low Potency of Indian Dust Mite Allergen Skin Prick Test Extracts Compared to FDA-Approved Extracts: A Double-Blinded Randomized Control Trial

by Devasahayam J. Christopher BSc, DTCD, DNB, FICS, FAPSR, FRCP(Glasg), FCCP, Narmada Ashok MBBS, DNB, DAA, MBA, MRCPCH, Aruna Ravivarma BSc(N), MBA, MSc, Deepa Shankar BSc, PG Dip in Adv. Respiratory Therapy, Erik Peterson MAS(Appl Statistics), Phuong T. Dinh MBA, MHA, P. K. Vedanthan MD
Published 2018-09-01